Practical Medical Management of Crohn's Disease

Overview

Journal ISRN Gastroenterol

Specialty Gastroenterology

Date 2013 Dec 6

PMID 24307950

Citations 6

Authors

Bulent Baran

Cetin Karaca

Affiliations

Soon will be listed here.

Abstract

Crohn's disease is a chronic inflammatory disease of diagnostic and therapeutic challenges. After proper diagnosis, treatment decisions must be made on precise clinical judgment. During the course of the disease there are variable clinical features, so each case must be managed individually. Physicians who care for patients with Crohn's disease should be prepared for treatment options in different states of the disease and possible complications of both the disease and medications. This paper will focus on the management of Crohn's disease. We aim to discuss current treatment options in different presentations of the disease and to provide algorithmic management strategy.

Citing Articles

Medical Management of Crohn's Disease.

Gade A, Douthit N, Townsley E Cureus. 2020; 12(5):e8351.

PMID: 32617224 PMC: 7325380. DOI: 10.7759/cureus.8351.

Host engulfment pathway controls inflammation in inflammatory bowel disease.

Sayed I, Suarez K, Lim E, Singh S, Pereira M, Ibeawuchi S FEBS J. 2020; 287(18):3967-3988.

PMID: 32003126 PMC: 7390677. DOI: 10.1111/febs.15236.

Crohn's Disease: Potential Drugs for Modulation of Autophagy.

Azzman N Medicina (Kaunas). 2019; 55(6).

PMID: 31146413 PMC: 6630681. DOI: 10.3390/medicina55060224.

Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial.

Yilmaz I, Dolar M, Ozpinar H Turk J Gastroenterol. 2019; 30(3):242-253.

PMID: 30662004 PMC: 6428516. DOI: 10.5152/tjg.2018.18227.

Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.

Ling C, Gavin M, Hanson J, McCarthy D Dig Dis Sci. 2018; 63(7):1751-1755.

PMID: 29934698 DOI: 10.1007/s10620-018-5135-z.

References

Forrest K, Symmons D, Foster P . Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?. Aliment Pharmacol Ther. 2004; 20(10):1035-43. DOI: 10.1111/j.1365-2036.2004.02270.x. View

Khan K, Ullman T, Ford A, Abreu M, Abadir A, Abadir A . Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011; 106(4):661-73. DOI: 10.1038/ajg.2011.72. View

Harvey R, Bradshaw J . A simple index of Crohn's-disease activity. Lancet. 1980; 1(8167):514. DOI: 10.1016/s0140-6736(80)92767-1. View

Lichtenstein G, Hanauer S, Sandborn W . Management of Crohn's disease in adults. Am J Gastroenterol. 2009; 104(2):465-83. DOI: 10.1038/ajg.2008.168. View

Wagtmans M, Verspaget H, Lamers C, van Hogezand R . Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Am J Gastroenterol. 1997; 92(9):1467-71. View

Van Assche G, Magdelaine-Beuzelin C, DHaens G, Baert F, Noman M, Vermeire S . Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology. 2008; 134(7):1861-8. DOI: 10.1053/j.gastro.2008.03.004. View

Hanauer S, Sandborn W, Rutgeerts P, Fedorak R, Lukas M, MacIntosh D . Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006; 130(2):323-33. DOI: 10.1053/j.gastro.2005.11.030. View

Sandborn W, Hanauer S, Rutgeerts P, Fedorak R, Lukas M, MacIntosh D . Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut. 2007; 56(9):1232-9. PMC: 2701613. DOI: 10.1136/gut.2006.106781. View

Sands B, Anderson F, Bernstein C, Chey W, Feagan B, Fedorak R . Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004; 350(9):876-85. DOI: 10.1056/NEJMoa030815. View

10.

Teruel C, Lopez-San Roman A, Bermejo F, Taxonera C, Perez-Calle J, Gisbert J . Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. Am J Gastroenterol. 2010; 105(9):2003-8. DOI: 10.1038/ajg.2010.138. View

11.

Present D, Rutgeerts P, Targan S, Hanauer S, Mayer L, van Hogezand R . Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999; 340(18):1398-405. DOI: 10.1056/NEJM199905063401804. View

12.

Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M . The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis. 2010; 4(1):7-27. DOI: 10.1016/j.crohns.2009.12.003. View

13.

Te H, Schiano T, Kuan S, Hanauer S, Conjeevaram H, Baker A . Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2000; 95(11):3150-6. DOI: 10.1111/j.1572-0241.2000.03287.x. View

14.

Colombel J, Sandborn W, Reinisch W, Mantzaris G, Kornbluth A, Rachmilewitz D . Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362(15):1383-95. DOI: 10.1056/NEJMoa0904492. View

15.

Pearson D, May G, Fick G, Sutherland L . Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev. 2000; (2):CD000067. DOI: 10.1002/14651858.CD000067. View

16.

Maeda Y, Ng S, Durdey P, Burt C, Torkington J, Rao P . Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg. 2010; 97(9):1340-7. DOI: 10.1002/bjs.7121. View

17.

Seow C, Benchimol E, Griffiths A, Otley A, Steinhart A . Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008; (3):CD000296. DOI: 10.1002/14651858.CD000296.pub3. View

18.

BERNSTEIN L, Frank M, Brandt L, BOLEY S . Healing of perineal Crohn's disease with metronidazole. Gastroenterology. 1980; 79(2):357-65. View

19.

Tanaka S, Matsuo K, Sasaki T, Nakano M, Sakai K, Beppu R . Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?. Hepatogastroenterology. 2010; 57(97):3-7. View

20.

Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W . Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther. 2003; 18(11-12):1113-20. DOI: 10.1046/j.1365-2036.2003.01793.x. View